fingolimod hydrochloride has been researched along with Schizophrenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, W; Guo, W; Hu, X; Li, T; Ma, X; Ni, P; Qi, X; Wang, Q; Wei, L; Yu, X; Zhao, L | 1 |
| Akhondzadeh, S; Amanollahi, M; Ardakani, MK; Basti, FA; Jameie, M; Karbalaee, M; Mokhtari, S; Moradi, K; Parsaei, M; TaghaviZanjani, F | 1 |
| Breier, A; Francis, MM; Hummer, TA; Kovacs, RJ; Liffick, E; Mehdiyoun, NF; Visco, AC; Vohs, JL; Yang, Z; Zhang, Y | 1 |
2 trial(s) available for fingolimod hydrochloride and Schizophrenia
| Article | Year |
|---|---|
Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Fingolimod Hydrochloride; Humans; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia.
Topics: Anisotropy; Brain; Cognition; Diffusion Tensor Imaging; Fingolimod Hydrochloride; Humans; Lysophospholipids; Magnetic Resonance Imaging; Pilot Projects; Schizophrenia; Sphingosine; White Matter | 2021 |
1 other study(ies) available for fingolimod hydrochloride and Schizophrenia
| Article | Year |
|---|---|
Fingolimod ameliorates schizophrenia-like cognitive impairments induced by phencyclidine in male rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia | 2023 |